Schizophrenia Bulletin Open,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Jan. 1, 2023
A
key
issue
in
both
research
and
clinical
work
with
youth
at
high
risk
(CHR)
of
psychosis
is
that
there
are
clearly
heterogenous
outcomes
addition
to
the
development
psychosis.
Thus,
it
important
capture
psychopathologic
CHR
group
develop
a
core
assessment
set
may
help
dissecting
heterogeneity
aid
progress
toward
new
treatments.
In
assessing
psychopathology
often
poor
social
role
functioning,
we
be
missing
perspectives
individuals
themselves.
It
consider
by
using
patient-reported
outcome
measures
(PROMs).
This
systematic
review
PROMs
was
conducted
based
on
comprehensive
search
several
databases
followed
Preferred
Reporting
Items
for
Systematic
reviews
Meta-Analyses
(PRISMA)
guidelines.
Sixty-four
publications
were
included
examining
symptoms,
quality
life,
self-perceptions,
stress,
resilience.
Typically,
not
primary
focus
studies
reviewed.
The
summarized
here
fit
results
published
elsewhere
literature
interviewer
measures.
However,
very
few
used
validated
or
youth.
There
recommendations
determining
use
CHR.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: May 2, 2023
To
harmonize
two
ascertainment
and
severity
rating
instruments
commonly
used
for
the
clinical
high
risk
syndrome
psychosis
(CHR-P):
Structured
Interview
Psychosis-risk
Syndromes
(SIPS)
Comprehensive
Assessment
of
At-Risk
Mental
States
(CAARMS).
Current Psychiatry Reports,
Journal Year:
2023,
Volume and Issue:
25(11), P. 683 - 698
Published: Sept. 27, 2023
This
review
highlights
recent
advances
in
the
prediction
and
treatment
of
psychotic
conversion.
Over
past
25
years,
research
into
prodromal
phase
illness
has
expanded
with
promise
early
identification
individuals
at
clinical
high
risk
(CHR)
for
psychosis
who
are
likely
to
convert
psychosis.
